Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors

33 participants · First posted Apr 27, 2015

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

18 participants · First posted Dec 18, 2024

NWRD09 for HPV-16 Related Cervical HSIL

9 participants · First posted Jul 2, 2025

REC-601

HPV E6 therapeutic vaccine

HPV-16 trojan peptide vaccine

南京易腾药物研究院有限公司

湖南尚众合生物医药有限公司

Merck & Co Inc

United States

Merck's Gardasil Approved in China for HPV Prevention in Males

Merck's Gardasil 9 Shows Positive Phase 3 Results in Japanese Males

Merck Reports Long-Term HPV Vaccine Efficacy Data Spanning Up to 18 Years